Drug factory · FDA FEI 1000220178

Curia Global, Inc.

Albany, New York, United States

Matched to FDA's records by company name, because this plant's registration on the label has expired.

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, May 9, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2010: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
BuprenorphineTests it Indivior Inc. 12496-0100, 12496-0300
RisperidoneTests it Indivior Inc. 12496-0090, 12496-0120

FDA inspection history

EndedResultProgramProblems noted
May 9, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 15, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Dec 12, 2013Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 13, 2011No problems foundDrug Quality Assurance—
Aug 18, 2010No problems foundDrug Quality Assurance—